141st APHA Annual Meeting

In This section

275809
Occurrence of pharmaceuticals and their by-products in drinking water and the environment

Tuesday, November 5, 2013

Eileen Murphy, Ph.D. , Ernest Mario School of Pharmacy, Dean's Office, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ
As analytical instrumentation used to monitor water for contaminants improves, our ability to detect very small amounts of chemicals in water samples, including medications and their by-products, increases. Numerous regional and nationwide investigations on water and drinking water quality conducted by state and federal scientists have shown the presence of low levels of unregulated contaminants in water samples. Examples of these unregulated contaminants include pharmaceuticals and their by-products, antibiotics, hormones, personal care products, and various industrial and commercial products. In fact, unregulated contaminants have been detected in virtually all water systems where such analysis has been conducted. While the contaminants include chemicals like flame retardants and pesticides, studies also show an alarming number of medications in the water. In several studies conducted in New Jersey, carbamazepine, gitoxiginen and cotinine were detected in water samples. The levels are not high enough to be of health significance by themselves (1 ug/L or lower), but in combination with other contaminants, may pose ecological and human health issues. Further, although toxicity testing that is required for new pharmaceuticals and pesticides provides some information about their potential health effects, no such testing is required for their environmental transformation products or for other domestic and industrial chemicals. Given the large number of chemicals released into the environment either through discharges or through domestic/industrial/ commercial use, it is not surprising that various combinations of mixtures of chemicals have been found in water samples. Several issues are raised that are of concern to public health professionals: 1) what is the potential impact on human health and the environment; 2) how might these unregulated contaminants interact with other naturally-occurring or regulated contaminants in the water; and 3) what measure may be effective to treat or to prevent the occurrence of these substances in drinking water. Medical health professionals and patients can be instrumental in preventing and reducing the release of these products to the environment by taking some simple steps regarding their over-the-counter (OTC) and prescription medications. These steps include using the drugs according to the label instructions and returning unused OTC and prescription medicines to state take-back programs rather than disposing in the trash or flushing down the toilet.

Learning Areas:
Environmental health sciences

Learning Objectives:
Evaluate the correlation between pharmaceutical use and disposal on environmental contamination Compare the contribution of medication use versus medication disposal on occurrence of pharmaceuticals in drinking water

Keywords: Drinking Water Quality, Environment

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have conducted the studies described in the abstract and have maintained knowledge of the literature on the subject matter. I have Ph.D. in Environmental Science and served as a Research Scientist and Director of the Division of Science and Research for the NJ Dept. of Environmental Protection for 20 years working in the area of drinking water quality. For the past 2 years at the School of Pharmacy, I have continued the work.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.